Td Asset Management Inc Roivant Sciences Ltd. Transaction History

Td Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$9.87 - $11.8 $3.98 Million - $4.75 Million	-402,892 Reduced 81.54%	91,192 $961,000
Q4 2023 Feb 12, 2024	SELL	$8.38 - $11.58 $6.08 Million - $8.4 Million	-725,496 Reduced 59.49%	494,084 $5.55 Million
Q3 2023 Oct 27, 2023	BUY	$9.76 - $13.19 $11.9 Million - $16.1 Million	1,219,580 New	1,219,580 $14.2 Million

311

508M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.94B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.